Form 8-K - Current report:
SEC Accession No. 0001104659-23-099306
Filing Date
2023-09-08
Accepted
2023-09-08 16:15:25
Documents
14
Period of Report
2023-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325730d1_8k.htm   iXBRL 8-K 29949
2 EXHIBIT 10.1 tm2325730d1_ex10-1.htm EX-10.1 15703
6 GRAPHIC tm2325730d1_ex10-1img01.jpg GRAPHIC 9320
  Complete submission text file 0001104659-23-099306.txt   235863

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230908.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230908_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230908_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2325730d1_8k_htm.xml XML 3300
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 231245450
SIC: 2834 Pharmaceutical Preparations